TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/22/18 17:00 | 3/20/18 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Holubow Fred | MN | D | M.d | 0 | 0.00 | 0 | 2 | 16 | 15 | D | |||||||||||||||
6/1/07 19:54 | 5/31/07 | MEND | Micrus Endovascular Corp | Health | MdEq | Surgical & Medical Instrument | Holubow Fred | CA | D | S | -109 | 21.27 | 0 | -5 | -22 | 18 | D | ||||||||||||||||
5/8/07 17:24 | 5/4/07 | BPA | Biosante Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Holubow Fred | IL | D | S.m | -51 | 6.78 | 0 | -8 | -11 | 61 | D | |||||||||||||||
7/21/06 17:35 | 7/19/06 | MEND | Micrus Endovascular Corp | Health | MdEq | Surgical & Medical Instrument | Holubow Fred | CA | D | S | -79 | 11.89 | 0 | -7 | -22 | 23 | D | ||||||||||||||||
10/18/04 17:28 | 10/14/04 | BPA | Biosante Pharmaceuticals Inc | WY | Health | BioPrd | Biological Products, (No Diag | Holubow Fred | IL | D | M.d | 21 | 2.85 | 0 | 8 | 12 | 70 | D | |||||||||||||||
8/6/03 17:14 | 8/4/03 | BISP | Biosante Pharmaceuticals Inc | WY | Health | BioPrd | Biological Products, (No Diag | Holubow Fred | D | P.d | 323 | 2.15 | 0 | 150 | 250 | 210 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |